References
- Abeliovich A and Gitler AD (2016) Defects in trafficking bridge Parkinson's disease pathology and genetics. Nature 539, 207-216 https://doi.org/10.1038/nature20414
- Moss J and Bolam JP (2008) A dopaminergic axon lattice in the striatum and its relationship with cortical and thalamic terminals. J Neurosci 28, 11221-11230 https://doi.org/10.1523/JNEUROSCI.2780-08.2008
- Matsuda W, Furuta T, Nakamura KC et al (2009) Single nigrostriatal dopaminergic neurons form widely spread and highly dense axonal arborizations in the neostriatum. J Neurosci 29, 444-453 https://doi.org/10.1523/JNEUROSCI.4029-08.2009
- Paisan-Ruiz C, Jain S, Evans EW et al (2004) Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease. Neuron 44, 595-600 https://doi.org/10.1016/j.neuron.2004.10.023
- Zimprich A, Biskup S, Leitner P et al (2004) Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Neuron 44, 601-607 https://doi.org/10.1016/j.neuron.2004.11.005
- Funayama M, Hasegawa K, Ohta E et al (2005) An LRRK2 mutation as a cause for the parkinsonism in the original PARK8 family. Ann Neurol 57, 918-921 https://doi.org/10.1002/ana.20484
- Nalls MA, Pankratz N, Lill CM et al (2014) Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease. Nat Genet 46, 989-993 https://doi.org/10.1038/ng.3043
- Lesage S, Ibanez P, Lohmann E et al (2005) G2019S LRRK2 mutation in french and north african families with Parkinson's disease. Ann Neurol 58, 784-787 https://doi.org/10.1002/ana.20636
- Benamer HT and de Silva R (2010) LRRK2 G2019S in the North African population: a review. Eur Neurol 63, 321-325 https://doi.org/10.1159/000279653
- Cookson MR (2010) The role of leucine-rich repeat kinase 2 (LRRK2) in Parkinson's disease. Nat Rev Neurosci 11, 791-797 https://doi.org/10.1038/nrn2935
- Paisan-Ruiz C, Lewis PA and Singleton AB (2013) LRRK2: cause, risk, and mechanism. J Parkinsons Dis 3, 85-103 https://doi.org/10.3233/JPD-130192
- Wang X, Yan MH, Fujioka H et al (2012) LRRK2 regulates mitochondrial dynamics and function through direct interaction with DLP1. Hum Mol Genet 21, 1931-1944 https://doi.org/10.1093/hmg/dds003
- Orenstein SJ, Kuo SH, Tasset I et al (2013) Interplay of LRRK2 with chaperone-mediated autophagy. Nat Neurosci 16, 394-406 https://doi.org/10.1038/nn.3350
- Parisiadou L, Xie C, Cho HJ et al (2009) Phosphorylation of ezrin/radixin/moesin proteins by LRRK2 promotes the rearrangement of actin cytoskeleton in neuronal morphogenesis. J Neurosci 29, 13971-13980 https://doi.org/10.1523/JNEUROSCI.3799-09.2009
- Martin I, Kim JW, Lee BD et al (2014) Ribosomal protein s15 phosphorylation mediates LRRK2 neurodegeneration in Parkinson's disease. Cell 157, 472-485 https://doi.org/10.1016/j.cell.2014.01.064
- Trinh J, Guella I and Farrer MJ (2014) Disease penetrance of late-onset parkinsonism: a meta-analysis. JAMA Neurol 71, 1535-1539 https://doi.org/10.1001/jamaneurol.2014.1909
- West AB, Moore DJ, Biskup S et al (2005) Parkinson's disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity. Proc Natl Acad Sci U S A 102, 16842-16847 https://doi.org/10.1073/pnas.0507360102
- Greggio E, Jain S, Kingsbury A et al (2006) Kinase activity is required for the toxic effects of mutant LRRK2/dardarin. Neurobiol Dis 23, 329-341 https://doi.org/10.1016/j.nbd.2006.04.001
- Lee BD, Shin JH, VanKampen J et al (2010) Inhibitors of leucine-rich repeat kinase-2 protect against models of Parkinson's disease. Nat Med 16, 998-1000 https://doi.org/10.1038/nm.2199
- Smith WW, Pei Z, Jiang H, Dawson VL, Dawson TM and Ross CA (2006) Kinase activity of mutant LRRK2 mediates neuronal toxicity. Nat Neurosci 9, 1231-1233 https://doi.org/10.1038/nn1776
- West AB, Moore DJ, Choi C et al (2007) Parkinson's disease-associated mutations in LRRK2 link enhanced GTP-binding and kinase activities to neuronal toxicity. Hum Mol Genet 16, 223-232 https://doi.org/10.1093/hmg/ddl471
- Lee BD, Dawson VL and Dawson TM (2012) Leucine-rich repeat kinase 2 (LRRK2) as a potential therapeutic target in Parkinson's disease. Trends Pharmacol Sci 33, 365-373 https://doi.org/10.1016/j.tips.2012.04.001
- Biskup S, Moore DJ, Celsi F et al (2006) Localization of LRRK2 to membranous and vesicular structures in mammalian brain. Ann Neurol 60, 557-569 https://doi.org/10.1002/ana.21019
- Shin N, Jeong H, Kwon J et al (2008) LRRK2 regulates synaptic vesicle endocytosis. Exp Cell Res 314, 2055-2065 https://doi.org/10.1016/j.yexcr.2008.02.015
- Piccoli G, Condliffe SB, Bauer M et al (2011) LRRK2 controls synaptic vesicle storage and mobilization within the recycling pool. J Neurosci 31, 2225-2237 https://doi.org/10.1523/JNEUROSCI.3730-10.2011
- Alegre-Abarrategui J, Christian H, Lufino MM et al (2009) LRRK2 regulates autophagic activity and localizes to specific membrane microdomains in a novel human genomic reporter cellular model. Hum Mol Genet 18, 4022-4034 https://doi.org/10.1093/hmg/ddp346
- Manzoni C, Denny P, Lovering RC and Lewis PA (2015) Computational analysis of the LRRK2 interactome. PeerJ 3, e778 https://doi.org/10.7717/peerj.778
- Tong Y, Yamaguchi H, Giaime E et al (2010) Loss of leucine-rich repeat kinase 2 causes impairment of protein degradation pathways, accumulation of alpha-synuclein, and apoptotic cell death in aged mice. Proc Natl Acad Sci U S A 107, 9879-9884 https://doi.org/10.1073/pnas.1004676107
- Dodson MW, Zhang T, Jiang C, Chen S and Guo M (2012) Roles of the Drosophila LRRK2 homolog in Rab7-dependent lysosomal positioning. Hum Mol Genet 21, 1350-1363 https://doi.org/10.1093/hmg/ddr573
- Stenmark H (2009) Rab GTPases as coordinators of vesicle traffic. Nat Rev Mol Cell Biol 10, 513-525 https://doi.org/10.1038/nrm2728
- Hutagalung AH and Novick PJ (2011) Role of Rab GTPases in membrane traffic and cell physiology. Physiol Rev 91, 119-149 https://doi.org/10.1152/physrev.00059.2009
- Rivero-Rios P, Gomez-Suaga P, Fernandez B et al (2015) Alterations in late endocytic trafficking related to the pathobiology of LRRK2-linked Parkinson's disease. Biochem Soc Trans 43, 390-395 https://doi.org/10.1042/BST20140301
- MacLeod DA, Rhinn H, Kuwahara T et al (2013) RAB7L1 interacts with LRRK2 to modify intraneuronal protein sorting and Parkinson's disease risk. Neuron 77, 425-439 https://doi.org/10.1016/j.neuron.2012.11.033
- Waschbusch D, Michels H, Strassheim S et al (2014) LRRK2 transport is regulated by its novel interacting partner Rab32. PLoS One 9, e111632 https://doi.org/10.1371/journal.pone.0111632
- Beilina A, Rudenko IN, Kaganovich A et al (2014) Unbiased screen for interactors of leucine-rich repeat kinase 2 supports a common pathway for sporadic and familial Parkinson disease. Proc Natl Acad Sci U S A 111, 2626-2631 https://doi.org/10.1073/pnas.1318306111
- Gomez-Suaga P, Rivero-Rios P, Fdez E et al (2014) LRRK2 delays degradative receptor trafficking by impeding late endosomal budding through decreasing Rab7 activity. Hum Mol Genet 23, 6779-6796 https://doi.org/10.1093/hmg/ddu395
- Heo HY, Kim KS and Seol W (2010) Coordinate regulation of neurite outgrowth by LRRK2 and Its interactor, Rab5. Exp Neurobiol 19, 97-105 https://doi.org/10.5607/en.2010.19.2.97
- Jeong GR, Jang EH, Bae JR et al (2018) Dysregulated phosphorylation of Rab GTPases by LRRK2 induces neurodegeneration. Mol Neurodegener 13, 8 https://doi.org/10.1186/s13024-018-0240-1
- Steger M, Tonelli F, Ito G et al (2016) Phosphoproteomics reveals that Parkinson's disease kinase LRRK2 regulates a subset of Rab GTPases. Elife 5, 12813 https://doi.org/10.7554/eLife.12813
- Liu Z, Bryant N, Kumaran R et al (2018) LRRK2 phosphorylates membrane-bound Rabs and is activated by GTP-bound Rab7L1 to promote recruitment to the trans-Golgi network. Hum Mol Genet 27, 385-395 https://doi.org/10.1093/hmg/ddx410
- Steger M, Diez F, Dhekne HS et al (2017) Systematic proteomic analysis of LRRK2-mediated Rab GTPase phosphorylation establishes a connection to ciliogenesis. Elife 6, 31012 https://doi.org/10.7554/eLife.31012
- Simon-Sanchez J, Schulte C, Bras JM et al (2009) Genome-wide association study reveals genetic risk underlying Parkinson's disease. Nat Genet 41, 1308-1312 https://doi.org/10.1038/ng.487
- Pihlstrom L, Rengmark A, Bjornara KA et al (2015) Fine mapping and resequencing of the PARK16 locus in Parkinson's disease. J Hum Genet 60, 357-362 https://doi.org/10.1038/jhg.2015.34
- Purlyte E, Dhekne HS, Sarhan AR et al (2018) Rab29 activation of the Parkinson's disease-associated LRRK2 kinase. EMBO J 37, 1-18 https://doi.org/10.15252/embj.201798099
- Eguchi T, Kuwahara T, Sakurai M et al (2018) LRRK2 and its substrate Rab GTPases are sequentially targeted onto stressed lysosomes and maintain their homeostasis. Proc Natl Acad Sci U S A 115, E9115-E9124 https://doi.org/10.1073/pnas.1812196115
- Mazzulli JR, Zunke F, Isacson O, Studer L and Krainc D (2016) alpha-Synuclein-induced lysosomal dysfunction occurs through disruptions in protein trafficking in human midbrain synucleinopathy models. Proc Natl Acad Sci U S A 113, 1931-1936 https://doi.org/10.1073/pnas.1520335113
- Cooper AA, Gitler AD, Cashikar A et al (2006) Alpha-synuclein blocks ER-Golgi traffic and Rab1 rescues neuron loss in Parkinson's models. Science 313, 324-328 https://doi.org/10.1126/science.1129462
- Gitler AD, Bevis BJ, Shorter J et al (2008) The Parkinson's disease protein alpha-synuclein disrupts cellular Rab homeostasis. Proc Natl Acad Sci U S A 105, 145-150 https://doi.org/10.1073/pnas.0710685105
- Dalfo E, Gomez-Isla T, Rosa JL et al (2004) Abnormal alpha-synuclein interactions with Rab proteins in alpha-synuclein A30P transgenic mice. J Neuropathol Exp Neurol 63, 302-313 https://doi.org/10.1093/jnen/63.4.302
- Saheki Y and De Camilli P (2012) Synaptic vesicle endocytosis. Cold Spring Harb Perspect Biol 4, a005645 https://doi.org/10.1101/cshperspect.a005645
- Matta S, Van Kolen K, da Cunha R et al (2012) LRRK2 controls an EndoA phosphorylation cycle in synaptic endocytosis. Neuron 75, 1008-1021 https://doi.org/10.1016/j.neuron.2012.08.022
- Gallop JL, Jao CC, Kent HM et al (2006) Mechanism of endophilin N-BAR domain-mediated membrane curvature. EMBO J 25, 2898-2910 https://doi.org/10.1038/sj.emboj.7601174
- Masuda M, Takeda S, Sone M et al (2006) Endophilin BAR domain drives membrane curvature by two newly identified structure-based mechanisms. EMBO J 25, 2889-2897 https://doi.org/10.1038/sj.emboj.7601176
- Bai J, Hu Z, Dittman JS, Pym EC and Kaplan JM (2010) Endophilin functions as a membrane-bending molecule and is delivered to endocytic zones by exocytosis. Cell 143, 430-441 https://doi.org/10.1016/j.cell.2010.09.024
- Milosevic I, Giovedi S, Lou X et al (2011) Recruitment of endophilin to clathrin-coated pit necks is required for efficient vesicle uncoating after fission. Neuron 72, 587-601 https://doi.org/10.1016/j.neuron.2011.08.029
- Ambroso MR, Hegde BG and Langen R (2014) Endophilin A1 induces different membrane shapes using a conformational switch that is regulated by phosphorylation. Proc Natl Acad Sci U S A 111, 6982-6987 https://doi.org/10.1073/pnas.1402233111
- Hill E, van Der Kaay J, Downes CP and Smythe E (2001) The role of dynamin and its binding partners in coated pit invagination and scission. J Cell Biol 152, 309-323 https://doi.org/10.1083/jcb.152.2.309
- Verstreken P, Koh TW, Schulze KL et al (2003) Synaptojanin is recruited by endophilin to promote synaptic vesicle uncoating. Neuron 40, 733-748 https://doi.org/10.1016/S0896-6273(03)00644-5
- Islam MS, Nolte H, Jacob W et al (2016) Human R1441C LRRK2 regulates the synaptic vesicle proteome and phosphoproteome in a Drosophila model of Parkinson's disease. Hum Mol Genet 25, 5365-5382
- Edvardson S, Cinnamon Y, Ta-Shma A et al (2012) A deleterious mutation in DNAJC6 encoding the neuronalspecific clathrin-uncoating co-chaperone auxilin, is associated with juvenile parkinsonism. PLoS One 7, e36458 https://doi.org/10.1371/journal.pone.0036458
- Koroglu C, Baysal L, Cetinkaya M, Karasoy H and Tolun A (2013) DNAJC6 is responsible for juvenile parkinsonism with phenotypic variability. Parkinsonism Relat Disord 19, 320-324 https://doi.org/10.1016/j.parkreldis.2012.11.006
- Nguyen M and Krainc D (2018) LRRK2 phosphorylation of auxilin mediates synaptic defects in dopaminergic neurons from patients with Parkinson's disease. Proc Natl Acad Sci U S A 115, 5576-5581 https://doi.org/10.1073/pnas.1717590115
- Belluzzi E, Gonnelli A, Cirnaru MD et al (2016) LRRK2 phosphorylates pre-synaptic N-ethylmaleimide sensitive fusion (NSF) protein enhancing its ATPase activity and SNARE complex disassembling rate. Mol Neurodegener 11, 1 https://doi.org/10.1186/s13024-015-0066-z
- Ryu JK, Jahn R and Yoon TY (2016) Review: Progresses in understanding N-ethylmaleimide sensitive factor (NSF) mediated disassembly of SNARE complexes. Biopolymers 105, 518-531 https://doi.org/10.1002/bip.22854
- Yu RC, Hanson PI, Jahn R and Brunger AT (1998) Structure of the ATP-dependent oligomerization domain of N-ethylmaleimide sensitive factor complexed with ATP. Nat Struct Biol 5, 803-811 https://doi.org/10.1038/1843
- Yun HJ, Park J, Ho DH et al (2013) LRRK2 phosphorylates Snapin and inhibits interaction of Snapin with SNAP-25. Exp Mol Med 45, e36 https://doi.org/10.1038/emm.2013.68
- Tian JH, Wu ZX, Unzicker M et al (2005) The role of Snapin in neurosecretion: snapin knock-out mice exhibit impaired calcium-dependent exocytosis of large dense-core vesicles in chromaffin cells. J Neurosci 25, 10546-10555 https://doi.org/10.1523/JNEUROSCI.3275-05.2005
- Shahmoradian SH, Lewis AJ, Genoud C et al (2019) Lewy pathology in Parkinson's disease consists of crowded organelles and lipid membranes. Nat Neurosci 22, 1099-1109 https://doi.org/10.1038/s41593-019-0423-2